Prevalence and risk factors for cancer of the uterine cervix among women living in Kinshasa, the Democratic Republic of the Congo: a cross-sectional study

Table 7 HPV genotyping results for women with ASCUS+ cytology

HPV genotype	Group 1 (HIV-positive women)	Groups 2, 3 and 4 (women with unknown or negative HIV status)
	Number of women with ASCUS + = 52	Number of women with ASCUS + = 133
	Number of samples in which HPV typing results were available = 50	Number of samples in which HPV typing results were available = 40
6	3 (6 %)	0 (0 %)
11	2 (4 %)	1 (3 %)
16	10 (20 %)	3 (8 %)^a
18	5 (10 %)	5 (13 %)
31	9 (18 %)	2 (5 %)
33	6 (12 %)	4 (10 %)
35	12 (24 %)	6 (15 %)
39	6 (12 %)	4 (10 %)
40	1 (2 %)	1 (3 %)
43	2 (4 %)	0 (0 %)
44	5 (10 %)	0 (0 %)
45	7 (14 %)	2 (5 %)
51	10 (20 %)	5 (13 %)
52	12 (24 %)	10 (25 %)
53	5 (10 %)	1 (3 %)
54	3 (6 %)	5 (13 %)
56	6 (12 %)	3 (8 %)
58	7 (14 %)	0 (0 %)
59	2 (4 %)	1 (3 %)
66	7 (14 %)	4 (10 %)
68	12 (24 %)	3 (8 %)
69	1 (2 %)	1 (3 %)
70	5 (10 %)	1 (3 %)
74	4 (8 %)	4 (10 %)
82	0 (0 %)	1 (3 %)

HPV human papillomavirus
ASCUS+ includes: atypical squamous cells of undetermined significance (ASCUS); atypical squamous cells; cannot rule out high-grade lesion (ASC-H); low- grade squamous intraepithelial lesions (LSIL), high-grade squamous intraepithelial lesions (HSIL) and carcinoma
^aIn addition to the three samples in which HPV16 was detected through the INNO-LiPA test, there were three samples in which both the Abbot Real Time and the GenoID test indicated the presence of HPV16

ISSN: 1750-9378